Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12110: Variant p.Asp227Asn

Collagen alpha-2(VI) chain
Gene: COL6A2
Feedback?
Variant information Variant position: help 227 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Aspartate (D) to Asparagine (N) at position 227 (D227N, p.Asp227Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 227 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1019 The length of the canonical sequence.
Location on the sequence: help TPHELYRNDYATMLPDSTEI D QDTINRIIKVMKHEAYGECY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         TPHELYRNDYATMLPDSTEIDQDTINRIIKVMKHEAYGECY

Mouse                         SPHELYRNNYATMRPDSTEIDQDTINRIIKVMKHEAYGECY

Chicken                       PPHDLYRSNYTITPKDALHIDENTIERIIKAMKHEAYAECY

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 21 – 1019 Collagen alpha-2(VI) chain
Domain 46 – 234 VWFA 1
Region 21 – 256 Nonhelical region



Literature citations
Submission
Chu M.-L.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2C2); SEQUENCE REVISION; VARIANTS ASN-227; ASN-399 AND HIS-680; Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
Baker N.L.; Moergelin M.; Peat R.; Goemans N.; North K.N.; Bateman J.F.; Lamande S.R.;
Hum. Mol. Genet. 14:279-293(2005)
Cited for: VARIANTS UCMD1B PRO-837 AND ASN-897 DEL; CHARACTERIZATION OF VARIANTS UCMD1B PRO-837 AND ASN-897 DEL; VARIANTS ASN-227; ASN-399 AND HIS-680; Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.
Lampe A.K.; Dunn D.M.; von Niederhausern A.C.; Hamil C.; Aoyagi A.; Laval S.H.; Marie S.K.; Chu M.-L.; Swoboda K.; Muntoni F.; Bonnemann C.G.; Flanigan K.M.; Bushby K.M.D.; Weiss R.B.;
J. Med. Genet. 42:108-120(2005)
Cited for: VARIANTS BTHLM1B SER-700 AND ARG-777; VARIANTS UCMD1B ARG-283; HIS-498; ARG-531; ARG-777 AND SER-876; VARIANTS LYS-106; ASN-227; ASN-399; GLN-489; SER-518; HIS-680; CYS-724; HIS-784; GLY-804; GLN-853 AND ARG-935; Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
Baker N.L.; Moergelin M.; Pace R.A.; Peat R.A.; Adams N.E.; Gardner R.J.; Rowland L.P.; Miller G.; De Jonghe P.; Ceulemans B.; Hannibal M.C.; Edwards M.; Thompson E.M.; Jacobson R.; Quinlivan R.C.M.; Aftimos S.; Kornberg A.J.; North K.N.; Bateman J.F.; Lamande S.R.;
Ann. Neurol. 62:390-405(2007)
Cited for: VARIANT BTHLM1B LEU-932; VARIANTS ASN-227; ASN-399; HIS-680 AND ARG-895;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.